Literature DB >> 22484190

Recent advances in pathologic evaluation and reporting of melanoma.

Rahel Mathew1, Jane L Messina.   

Abstract

Recent changes to the staging of melanoma, coupled with advances in surgical and medical treatment, have resulted in new methods for diagnostic evaluation and reporting of melanocytic lesions by pathologists. This review provides an update on recent changes in evaluation and reporting of primary melanoma, evaluation of regional lymph nodes, especially sentinel nodes, and the workup of distant metastatic melanoma specimens. A brief summary of commercially available molecular diagnostic techniques and their application to practice is included.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22484190     DOI: 10.1053/j.seminoncol.2012.01.005

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  3 in total

1.  Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Authors:  S Martín-Algarra; M T Fernández-Figueras; J A López-Martín; A Santos-Briz; A Arance; M D Lozano; A Berrocal; J J Ríos-Martín; E Espinosa; J L Rodríguez-Peralto
Journal:  Clin Transl Oncol       Date:  2013-10-16       Impact factor: 3.405

2.  Euphorbia fischeriana Steud inhibits malignant melanoma via modulation of the phosphoinositide-3-kinase/Akt signaling pathway.

Authors:  Meng-Hua Dong; Qian Zhang; Yuan-Yuan Wang; Bai-Sui Zhou; Yu-Fei Sun; Qiang Fu
Journal:  Exp Ther Med       Date:  2016-02-09       Impact factor: 2.447

3.  Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.

Authors:  Hollis Viray; William R Bradley; Kurt A Schalper; David L Rimm; Bonnie E Gould Rothberg
Journal:  Arch Pathol Lab Med       Date:  2013-08       Impact factor: 5.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.